Zusammenfassung
Nachahmer oder sogenannte Mimicker sind benigne Läsionen, die aufgrund der Architektur, des Wachstumsmusters oder der zellulären Atypien einem Prostatakarzinom oder einer hochgradigen intraepithelialen Neoplasie der Prostatadrüsen (HGPIN) ähneln. Dazu gehören die normalen anatomischen Strukturen, verschiedene Formen der Atrophie, die sklerosierende Adenose, die Metaplasien des Drüsenepithels, die reaktiven Atypien der Prostatadrüsen im Rahmen der Ischämie, der Entzündung oder nach Bestrahlung. Die Kenntnis solcher Läsionen mit deren zellulären Charakteristika und gegebenenfalls des immunhistologischen Profils erleichtern die Differenzialdiagnose in Zweifelsfällen.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Abdollah F, Briganti A, Suardi N, Castiglione F, Gallina A, Capitanio U, Montorsi F (2011) Metabolic syndrome and benign prostatic hyperplasia. Evidence of a potential relationship, hypothesized etiology, and prevention. Korean J Urol 52(8):507–516. https://doi.org/10.4111/kju.2011.52.8.507
Allan CH, Epstein JI (2001) Nephrogenic adenoma of the prostatic urethra. A mimicker of prostate adenocarcinoma. Am J Surg Pathol 25(6):802–808
Amin MB, Bostwick DG (1996) Pigment in prostatic epithelium and adenocarcinoma. A potential source of diagnostic confusion with seminal vesicular epithelium Mod Pathol Off J US Can Acad Pathol 9(7): 791–795
Ayala AG, Srigley JR, Ro JY, Abdul-Karim FW, Johnson DE (1986) Clear cell cribriform hyperplasia of prostate. Report of 10 cases. Am J Surg Pathol 10(10):665–671
Begnami MD, Quezado M, Pinto P, Linehan WM, Merino M (2007) Adenoid cystic/basal cell carcinoma of the prostate. Review and update. Arch Pathol Lab Med 131(4):637–640. https://doi.org/10.1043/1543-2165(2007)131[637:ABCCOT]2.0.CO;2
Beltran L, Ahmad AS, Sandu H, Kudahetti S, Soosay G, Møller H et al (2019) Histopathologic False-positive Diagnoses of Prostate Cancer in the Age of Immunohistochemistry. Am J Surg Pathol 43(3):361–368. https://doi.org/10.1097/PAS.0000000000001202
Bostwick DG, Chang L (1999) Overdiagnosis of prostatic adenocarcinoma. Semin Urol Oncol 17(4):199–205
Bostwick DG, Qian J (1995) Atypical adenomatous hyperplasia of the prostate Relationship with carcinoma in 217 whole-mount radical prostatectomies. Am J Surg Pathol 19(5):506
Bostwick DG, Egbert BM, Fajardo LF (1982) Radiation injury of the normal and neoplastic prostate. Am J Surg Pathol 6(6):541–551
Bostwick DG, Srigley J, Grignon D, Maksem J, Humphrey P, van der Kwast TH et al (1993) Atypical adenomatous hyperplasia of the prostate. Morphologic criteria for its distinction from well-differentiated carcinoma. Hum Pathol 24(8):819–832
Bostwick DG, Qian J, Ma J, Muir TE (2003) Mesonephric remnants of the prostate Incidence and histologic spectrum. Mod Pathol Off J US Can Acad Pathol 16(7):630–635. https://doi.org/10.1097/01.MP.0000074733.10777.78
Chan TY, Epstein JI (1999) Follow-up of atypical prostate needle biopsies suspicious for cancer. Urology 53(2):351–355
Cheng L, Shan A, Cheville JC, Qian J, Bostwick DG (1998) Atypical adenomatous hyperplasia of the prostate. A premalignant lesion? Cancer Res 58(3):389–391
Cheng L, Cheville JC, Bostwick DG (1999) Diagnosis of prostate cancer in needle biopsies after radiation therapy. Am J Surg Pathol 23(10):1173–1183
Cheng L, Bostwick DG (2010) Atypical sclerosing adenosis of the prostate. A rare mimic of adenocarcinoma. Histopathology 56(5):627–631. https://doi.org/10.1111/j.1365-2559.2010.03525.x
Cheng L, Davidson DD, Maclennan GT, Lopez-Beltran A, Montironi R, Wang M et al (2013) Atypical adenomatous hyperplasia of prostate lacks TMPRSS2-ERG gene fusion. Am J Surg Pathol 37(10):1550–1554. https://doi.org/10.1097/PAS.0b013e318294e9bc
Cheng L, Montironi R, Davidson DD, Wang M, Lopez-Beltran A, Zhang S (2019) Molecular evidence supporting the precursor nature of atypical adenomatous hyperplasia of the prostate. Mol Carcinog 58(7):1272–1278. https://doi.org/10.1002/mc.23009
Cina SJ, Silberman MA, Kahane H, Epstein JI (1997) Diagnosis of Cowper’s glands on prostate needle biopsy. Am J Surg Pathol 21(5):550–555
Compérat E, Varinot J, Srigley JR (2013) Lésions bénignes mimant le cancer de la prostate. Challenges diagnostiques. Ann Pathol 33(4):237–246. https://doi.org/10.1016/j.annpat.2013.06.005
Cunha GR, Wang YZ, Hayward SW, Risbridger GP (2001) Estrogenic effects on prostatic differentiation and carcinogenesis. Reprod Fertil Dev 13(4):285–296
Das DK, Hedlund PO, Lowhagen T, Esposti PL (1991) Squamous metaplasia in hormonally treated prostatic cancer. Significance during follow-up. Urology 38(1):70–75
Devaraj LT, Bostwick DG (1993) Atypical basal cell hyperplasia of the prostate. Immunophenotypic profile and proposed classification of basal cell proliferations. Am J Surg Pathol 17(7):645–659
de Marzo AM, Marchi VL, Epstein JI, Nelson WG (1999) Proliferative inflammatory atrophy of the prostate. Implications for prostatic carcinogenesis. Am J Pathol 155(6):1985–1992. https://doi.org/10.1016/S0002-9440(10)65517-4
de Marzo AM, Platz EA, Epstein JI, Ali T, Billis A, Chan TY et al (2006) A working group classification of focal prostate atrophy lesions. Am J Surg Pathol 30(10):1281–1291. https://doi.org/10.1097/01.pas.0000213289.50660.be
de Nunzio C, Presicce F, Tubaro A (2016) Inflammatory mediators in the development and progression of benign prostatic hyperplasia. Nat Rev Urol 13(10):613–626. https://doi.org/10.1038/nrurol.2016.168
Epstein JI, Armas OA (1992) Atypical basal cell hyperplasia of the prostate. Am J Surg Pathol 16(12):1205–1214
Erbersdobler A (2013) Nichtneoplastische Veränderungen der Prostata. Warum sollten Pathologen sie kennen? Der Pathologe 34(5):429–435. https://doi.org/10.1007/s00292-013-1782-1
FRANKS LM (1954) Atrophy and hyperplasia in the prostate proper. J Pathol Bacteriol 68(2):617–621
Freitas DM, Andriole GL, Castro-Santamaria R, Freedland SJ, Moreira DM (2017) Extent of baseline prostate atrophy is associated with lower incidence of low- and high-grade prostate cancer on repeat biopsy. Urology 103:161–166. https://doi.org/10.1016/j.urology.2016.12.027
Gandaglia G, Briganti A, Gontero P, Mondaini N, Novara G, Salonia A et al (2013) The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH). BJU Int 112(4):432–441. https://doi.org/10.1111/bju.12118
Garcia FU, Haber MM, Chen X (2007) Prostatic basal cells in the peripheral and transitional zones. Zonal variation in morphology and in immunophenotype. Prostate 67(15):1686–1692. https://doi.org/10.1002/pros.20658
Garraway WM, Collins GN, Lee RJ (1991) High prevalence of benign prostatic hypertrophy in the community. Lancet (London, England) 338(8765):469–471. https://doi.org/10.1016/0140-6736(91)90543-x
Gaudin PB, Epstein JI (1995) Adenosis of the prostate. Histologic features in needle biopsy specimens. Am J Surg Pathol 19(7):737–747
Gaudin PB, Zelefsky MJ, Leibel SA, Fuks Z, Reuter VE (1999) Histopathologic effects of three-dimensional conformal external beam radiation therapy on benign and malignant prostate tissues. Am J Surg Pathol 23(9):1021–1031
Green WM, Hicks JL, de Marzo A, Illei PPB, Epstein JI (2013) Immunohistochemical evaluation of TMPRSS2-ERG gene fusion in adenosis of the prostate. Hum Pathol 44(9):1895–1901. https://doi.org/10.1016/j.humpath.2013.02.019
Grignon DJ, O’Malley FP (1993) Mucinous metaplasia in the prostate gland. Am J Surg Pathol 17(3):287–290
Grignon DJ, Ro JY, Srigley JR, Troncoso P, Raymond AK, Ayala AG (1992) Sclerosing adenosis of the prostate gland A lesion showing myoepithelial differentiation. Am J Surg Pathol 16(4):383–391
Hameed O, Humphrey PA (2010) Pseudoneoplastic mimics of prostate and bladder carcinomas. Arch Pathol Lab Med 134(3):427–443. https://doi.org/10.1043/1543-2165-134.3.427
Hammarsten J, Högstedt B (2001) Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. Eur Urol 39(2):151–158. https://doi.org/10.1159/000052430
Harik LR, O'Toole KM (2012) Nonneoplastic lesions of the prostate and bladder. Arch Pathol Lab Med 136(7):721–734. https://doi.org/10.5858/arpa.2011-0584-R
Howarth SM, Griffiths DFR, Varma M (2005) Paraganglion of the prostate gland. An uncommon mimic of prostate cancer in needle biopsies. Histopathology 47(1):114–115. https://doi.org/10.1111/j.1365-2559.2005.02043.x
Iczkowski KA, Ferguson KL, Grier DD, Hossain D, Banerjee SS, McNeal JE, Bostwick DG (2003) Adenoid cystic/basal cell carcinoma of the prostate. Clinicopathologic findings in 19 cases. Am J Surg Pathol 27(12):1523–1529
Jones EC, Clement PB, Young RH (1991) Sclerosing adenosis of the prostate gland. A clinicopathological and immunohistochemical study of 11 cases. Am J Surg Pathol 15(12):1171–1180
Kawabata K (1997) Paraganglion of the prostate in a needle biopsy. A potential diagnostic pitfall. Arch Pathol Lab Med 121(5):515–516
Lee TK, Ro JY (2018) Spectrum of cribriform proliferations of the prostate from benign to malignant. Arch Pathol Lab Med 142(8):938–946. https://doi.org/10.5858/arpa.2018-0005-RA
Leung CS, Srigley JR (1995) Distribution of lipochrome pigment in the prostate gland. Biological and diagnostic implications. Hum Pathol 26(12):1302–1307
Luque RJ, Lopez-Beltran A, Perez-Seoane C, Suzigan S (2003) Sclerosing adenosis of the prostate. Histologic features in needle biopsy specimens. Arch Pathol Lab Med 127(1):e14–e16. https://doi.org/10.1043/0003-9985(2003)127<e14:SAOT>2.0.CO;2
McKenney JK, Amin MB, Srigley JR, Jimenez RE, Ro JY, Grignon DJ, Young RH (2004) Basal cell proliferations of the prostate other than usual basal cell hyperplasia. A clinicopathologic study of 23 cases, including four carcinomas, with a proposed classification. Am J Surg Pathol 28(10):1289–1298
Milord RA, Kahane H, Epstein JI (2000) Infarct of the prostate gland. Experience on needle biopsy specimens. Am J Surg Pathol 24(10):1378–1384
Montironi R, Schulman CC (1998) Pathological changes in prostate lesions after androgen manipulation. J Clin Pathol 51(1):5–12. https://doi.org/10.1136/jcp.51.1.5
Moreira DM, O Freitas DM de, Nickel JC, Andriole GL, Castro-Santamaria R, Freedland SJ (2017) The combination of histological prostate atrophy and inflammation is associated with lower risk of prostate cancer in biopsy specimens. Prostate cancer prostatic Dis 20 (4): 413–417. https://doi.org/10.1038/pcan.2017.30.
Nelson WG, de Marzo AM, DeWeese TL (2001) The molecular pathogenesis of prostate cancer. Implications for prostate cancer prevention. Urology 57(4 Suppl 1):39–45
Ostrowski ML, Wheeler TM (1994) Paraganglia of the prostate. Location, frequency, and differentiation from prostatic adenocarcinoma. Am J Surg Pathol 18(4):412–420
Postma R, Schröder FH, van der Kwast TH (2005) Atrophy in prostate needle biopsy cores and its relationship to prostate cancer incidence in screened men. Urology 65(4):745–749. https://doi.org/10.1016/j.urology.2004.10.046
Putzi MJ, de Marzo AM (2000) Morphologic transitions between proliferative inflammatory atrophy and high-grade prostatic intraepithelial neoplasia. Urology 56(5):828–832
Rioux-Leclercq NC, Epstein JI (2002) Unusual morphologic patterns of basal cell hyperplasia of the prostate. Am J Surg Pathol 26(2):237–243
Roberts RO, Jacobson DJ, Rhodes T, Klee GG, Leiber MM, Jacobsen SJ (2004) Serum sex hormones and measures of benign prostatic hyperplasia. Prostate 61(2):124–131. https://doi.org/10.1002/pros.20080
Saboorian MH, Huffman H, Ashfaq R, Ayala AG, Ro JY (1997) Distinguishing Cowper’s glands from neoplastic and pseudoneoplastic lesions of prostate Immunohistochemical and ultrastructural studies. Am J Surg Pathol 21(9):1069–1074
Shah RB, Kunju LP, Shen R, LeBlanc M, Zhou M, Rubin MA (2004) Usefulness of basal cell cocktail (34betaE12 + p63) in the diagnosis of atypical prostate glandular proliferations. Am J Clin Pathol 122(4):517–523. https://doi.org/10.1309/WRM5-1C70-P1NB-FE4K
Shah RB, Zhou M, LeBlanc M, Snyder M, Rubin MA (2002) Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer. Am J Surg Pathol 26(9):1161–1168
Sheaff MT, Baithun SI (1997) Effects of radiation on the normal prostate gland. Histopathology 30(4):341–348
Shuman BA, Cohen JK, Miller RJ, Rooker GM, Olson PR (1997) Histological presence of viable prostatic glands on routine biopsy following cryosurgical ablation of the prostate. J Urol 157(2):552–555
Srigley JR (2004) Benign mimickers of prostatic adenocarcinoma. Mod Pathol Off J US Can Acad Pathol 17(3):328–348. https://doi.org/10.1038/modpathol.3800055
Thorson P, Swanson PE, Vollmer RT, Humphrey PA (2003) Basal cell hyperplasia in the peripheral zone of the prostate. Mod Pathol Off J US Can Acad Pathol 16(6):598–606. https://doi.org/10.1097/01.MP.0000073526.59270.6E
Vailancourt L, Ttu B, Fradet Y, Dupont A, Gomez J, Cusan L et al (1996) Effect of neoadjuvant endocrine therapy (combined androgen blockade) on normal prostate and prostatic carcinoma. A randomized study. Am J Surg Pathol 20(1):86–93
Varma M, Morgan M, O’Rourke D, Jasani B (2004) Prostate specific antigen (PSA) and prostate specific acid phosphatase (PSAP) immunoreactivity in benign seminal vesicle\ejaculatory duct epithelium. A potential pitfall in the diagnosis of prostate cancer in needle biopsy specimens. Histopathology 44(4):405–406. https://doi.org/10.1111/j.1365-2559.2004.01821.x
Yang XJ, McEntee M, Epstein JI (1998) Distinction of basaloid carcinoma of the prostate from benign basal cell lesions by using immunohistochemistry for bcl-2 and Ki-67. Hum Pathol 29(12):1447–1450
Young RH (1992) Nephrogenic adenomas of the urethra involving the prostate gland. A report of two cases of a lesion that may be confused with prostatic adenocarcinoma. Mod Pathol Off J US Can Acad Pathol 5(6):617–620
Sailer V, Stephan C, Wernert N, Perner S, Jung K, Dietel M, Kristiansen G (2013) Comparison of p40 (DeltaNp63) and p63 expression in prostate tissues–which one is the superior diagnostic marker for basal cells? Histopathology 63(1):50–56
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this chapter
Cite this chapter
Toma, M. (2020). Mimickers des Prostatakarzinoms. In: Perner, S., Sailer, VW. (eds) Histopathologische Diagnostik der Prostatastanzbiopsie . Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-60643-8_5
Download citation
DOI: https://doi.org/10.1007/978-3-662-60643-8_5
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-60642-1
Online ISBN: 978-3-662-60643-8
eBook Packages: Medicine (German Language)